Revolutionizing cancer monitoring
Personalized cancer monitoring with remarkable sensitivity from a simple blood sample
Because cancer is personal
Cancer affects everyone, from the patient to their loved ones. Each patient has a unique story, and every cancer is also entirely different. Despite that each tumor possesses its own set of DNA mutations, patients often undergo testing and treatment using the same standardized and inflexible methods.
More personal is more sensitive
Given the uniqueness of each tumor, a uniform testing approach may not be sensitive enough to detect cancer. For that reason we developed Simsen Personal™, a customized cancer DNA test for each patient, offering next level sensitivity and specificity for monitoring cancer.
Make cancer curable with ultrasensitive monitoring
Simsen Diagnostics is a Swedish biotech company that specializes in ultrasensitive technologies for cancer monitoring. Founded in 2020,
our mission is to make cancer a curable disease.
We envision a future where ultrasensitive analysis can revolutionize healthcare and contribute to faster, accurate, and more sensitive diagnoses of a wide range of diseases.
- Gustav Johansson, CEO
References
